Cyclacel Pharmaceuticals, Inc.
CYCC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $749,482 | $511,118 | $1,800,900 | $8,329,125 |
| - Cash | $3,137 | $3,378 | $18,345 | $36,559 |
| + Debt | $0 | $37 | $106 | $30 |
| Enterprise Value | $746,345 | $507,777 | $1,782,661 | $8,292,596 |
| Revenue | $43 | $420 | $0 | $0 |
| % Growth | -89.8% | – | – | – |
| Gross Profit | $43 | $420 | -$32 | -$43 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$11,998 | -$25,422 | -$27,624 | -$22,691 |
| % Margin | -27,902.3% | -6,052.9% | – | – |
| Net Income | -$11,212 | -$22,555 | -$21,198 | -$18,887 |
| % Margin | -26,074.4% | -5,370.2% | – | – |
| EPS Diluted | -1.36 | -28.67 | -28.5 | -32.1 |
| % Growth | 95.3% | -0.6% | 11.2% | – |
| Operating Cash Flow | -$7,990 | -$16,112 | -$20,827 | -$18,540 |
| Capital Expenditures | $0 | -$6 | -$7 | -$27 |
| Free Cash Flow | -$7,990 | -$16,118 | -$20,834 | -$18,567 |